CRAB Stages Important Cancer Biostatistics Conference
On August 14 and 15, the first Pacific Rim Cancer Biostatistics Conference took place at the historically-designated Washington Athletic Club (WAC) in Seattle, Washington.
With the generous support of our sponsors - the Institute of Statistical Mathematics (ISM) and Kakenhi (Japan Society for the Promotion of Science: Grants-in Aid for Scientific Research), we brought together well-renowned statisticians in oncology research to collectively share breakthroughs, foster innovation, and advance statistical methods to conquer cancer.
The two-day event was well attended by Statisticians, Professors of Biostatistics, and oncology research professionals with an international group of twenty highly-regarded speakers presenting on cutting edge sessions in the areas of clinical and translational research in oncology, prognostic analysis and risk prediction, predictive modeling and performance assessment, screening/epidemiology, and analysis of genomic/imaging data. The group even braved the rain and Seahawks game traffic to attend a post-conference dinner!
We thank our sponsors, presenters, partners and attendees for their partnership and participation and for helping to make the inaugural Pacific Rim Cancer Biostatistics Conference a tremendous success.
CRAB, Berg and BIDMC Align with PurpleStride Boston 2015
Berg Biosystems and Beth Israel Deaconess Medical Center (BIDMC) will join forces to fight pancreatic cancer at Purple Stride this Sunday, August 16, 2015 at Boston Common. BIDMC will serve as honorary chair of the Pancreatic Cancer Action Network (PanCAN) for the day. BIDMC will have a tent at Purple Stride Boston to represent its joint-mission with PanCAN, promote BIDMC clinical services, and build buzz around Project Survival in the community most affected by pancreatic cancer.
The event will increase visibility of Project Survival, a multi-institutional collaboration targeted at pancreatic cancer to discover breakthrough diagnostics and allow for development of targeted treatments against pancreatic cancer. To learn more about Project Survival please visit this link: http://bit.ly/1GSJwA5. Niven Narain, CEO of Berg Biosystems, discusses Project Survival in this Fox Business Interview on YouTube: https://youtu.be/FhnTsgJK9W8.
CRAB Aligned with Lung Cancer Awareness Group
CRAB joined with the "Community of Hope" - aligning our mission to help fight and raise awareness of lung cancer. On Saturday, August 8th 2015, CRAB's outreach committee, CRABCares, participated in the Breathe Deep Seattle fun-run/walk at Seward Park. The event was hosted by Lungevity. CRABCares members, their families and their friends enjoyed conversation. coffee and interactions with the greater lung cancer survivorship community. Smiles and stories were shared by attendees.
CRAB and Berg Honor Cancer Survivors at Fenway Park
July 10, 2015 - Researchers from Cancer Research And Biostatistics (CRAB), Berg Biosystems and Beth Israel Deaconess Memorial Hospital recognized cancer survivors at a Red Sox vs Yankees game at Fenway Park. CRAB researchers John Crowley, PhD and Amy Stoll-D’Astice, Dr. Ramesh Ramanathan, MD along with Dr. Jim Moser, MD from BIDMC and Niven Narain, CEO of Berg, gathered in Boston for a weekend meeting at Berg’s offices to discuss Project Survival, Berg’s multi-institutional initiative in pancreatic cancer targeted therapies. Amy Stoll-D'Astice called the Fenway Park event "a wonderful recognition of Pancreatic Cancer survivors with a team hoping to “hit it out of the ballpark” with Project Survival". Read more about Project Survival at this link: http://bit.ly/1GSJwA5.
2014 Annual Report Published
Click the image above to view or download the report.
Pancreatic Cancer Biomarker the Goal of “Project Survival”
SEATTLE, June 18, 2015 – Cancer Research And Biostatistics (CRAB) is working through our Pancreatic Cancer Research Team (PCRT) network on "Project Survival," a multi-institutional collaboration targeted at pancreatic cancer to discover breakthrough diagnostics and allow for development of targeted treatments against pancreatic cancer. CRAB and the PCRT network provide the essential infrastructure and expertise for a project with these lofty goals. You can view an interview with Niven Narain, CEO of Berg, with Diedre Bolton of Fox Business on her Risk & Reward show at this link: https://youtu.be/FhnTsgJK9W8.
More information about the project can be found here: http://bit.ly/1GSJwA5.
If you are interested in supporting cancer research please consider a donation to CRAB, a 5013c non-profit research institute. Click here to donate: http://www.crab.org/Donate.aspx